Indo Borax & Chemicals Board Approves Majority Acquisition of Kronox Lab Sciences

At a board meeting on August 20, 2026, the board of Indo Borax & Chemicals approved the acquisition of 2,38,44,000 equity shares [1]. These shares represent a face value of Rs 10 each, totaling 64.26% of the share capital of Kronox Lab Sciences [1].

Corporate transactions involving majority share purchases reshape ownership structures and governance dynamics between the entities involved. By clearing the acquisition of 64.26% of Kronox Lab Sciences' share capital, Indo Borax & Chemicals is positioning itself to hold a controlling interest in the company [1]. Transactions of this magnitude require board-level authorization, signaling an important milestone in the strategic alignment or consolidation plans of Indo Borax & Chemicals.

For investors following Indo Borax & Chemicals, the integration of a majority-owned asset representing over 64% of another entity's equity introduces structural changes [1]. Investors must evaluate how the incorporation of Kronox Lab Sciences' operations, financial assets, and liabilities will alter the consolidated balance sheet and future reporting cycles of Indo Borax & Chemicals.

Major corporate acquisitions carry inherent execution and integration risks. While the board has approved the acquisition of 2,38,44,000 equity shares [1], investors must consider potential operational hurdles, integration friction, and the allocation of capital required to successfully absorb a controlling 64.26% stake [1]. Market conditions and regulatory factors surrounding corporate takeovers also form part of the baseline risk assessment.

• Indo Borax & Chemicals held a board meeting on August 20, 2026 [1].
• The board approved the acquisition of a 64.26% majority stake in Kronox Lab Sciences [1].
• The transaction involves 2,38,44,000 equity shares with a face value of Rs 10 each [1].

• Indo Borax & Chemicals
• Kronox Lab Sciences

### What percentage of Kronox Lab Sciences is Indo Borax & Chemicals acquiring? Indo Borax & Chemicals is acquiring 64.26% of the share capital of Kronox Lab Sciences [1].

### How many shares are included in the approved acquisition? The board approved the acquisition of 2,38,44,000 equity shares [1].

### What is the face value of the shares being acquired? The equity shares have a face value of Rs 10 each [1].

### When did the board of Indo Borax & Chemicals approve this transaction? The board approval took place at a meeting held on August 20, 2026 [1].